-
Notifications
You must be signed in to change notification settings - Fork 172
/
ABBV.json
127 lines (127 loc) · 3.33 KB
/
ABBV.json
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
{
"name": "AbbVie",
"symbol": "ABBV",
"type": "stock",
"price": 100.00,
"drugs": [
{
"name": "Humira",
"revenue": {
"2023": 1000000000,
"2022": 900000000,
"2021": 800000000
}
},
{
"name": "Venclexta",
"mechanism": "BCL2 inhibitor",
"indication": "CLL",
"revenue": {
"2023": 1000000000,
"2022": 900000000,
"2021": 800000000
},
"economics": "Roche partnership"
},
{
"name": "Rinvoq",
"mechanism": "JAK inhibitor",
"indication": "RA",
"revenue": {
"2023": 1000000000,
"2022": 900000000,
"2021": 800000000
}
},
{
"name": "Skyrizi",
"mechanism": "IL-23 inhibitor",
"indication": "Psoriasis",
"revenue": {
"2023": 1000000000,
"2022": 900000000,
"2021": 800000000
}
},
{
"name": "Mavyret",
"mechanism": "NS5A inhibitor",
"indication": "Hepatitis C",
"revenue": {
"2023": 1000000000,
"2022": 900000000,
"2021": 800000000
}
},
{
"name": "Botox",
"mechanism": "Botulinum toxin",
"indication": "Aesthetic",
"revenue": {
"2023": 1000000000,
"2022": 900000000,
"2021": 800000000
}
},
{
"name": "Imbruvica",
"mechanism": "BTK inhibitor",
"indication": "CLL",
"revenue": {
"2023": 1000000000,
"2022": 900000000,
"2021": 800000000
}
},
{
"name": "Lupron",
"mechanism": "GnRH-a agonist",
"indication": "Prostate cancer",
"revenue": {
"2023": 1000000000,
"2022": 900000000,
"2021": 800000000
}
},
{
"name": "Synthroid",
"mechanism": "Thyroid hormone",
"indication": "Hypothyroidism",
"revenue": {
"2023": 1000000000,
"2022": 900000000,
"2021": 800000000
}
},
{
"name": "Creon",
"mechanism": "Pancreatic enzyme",
"indication": "Chronic pancreatitis",
"revenue": {
"2023": 1000000000,
"2022": 900000000,
"2021": 800000000
}
},
{
"name": "Restasis",
"mechanism": "",
"indication": "Dry eye",
"revenue": {
"2023": 1000000000,
"2022": 900000000,
"2021": 800000000
}
},
{
"name": "Duodopa",
"mechanism": "L-DOPA",
"indication": "Parkinson's disease",
"revenue": {
"2023": 1000000000,
"2022": 900000000,
"2021": 800000000
}
}
]
}